AbstractRedirecting retroviral vector transduction simply by insertion of a ligand into the envelope (Env) protein has met with several obstacles. For example, virions targeted to epidermal growth factor receptor (EGFR), after receptor binding, rapidly traffic to the lysosomes, where they are degraded. Exotoxin A of Pseudomonas aeruginosa has the ability to translocate from endosomes to the cytoplasm by means of a translocation domain (TLD). We generated a series of chimeric Env proteins of Moloney murine leukemia virus containing EGFR ligands, where TLD was inserted into different regions. These chimeric proteins were successfully produced, if the translocation domain was not located at the immediate N-terminus of Env. The ability to trans...
AbstractWe have constructed chimeric retroviral envelopes displaying N-terminal polypeptides that ar...
We constructed a hybrid Moloney murine leukaemia virus (MoMLV) bearing both a chimeric CD4 and the w...
AbstractPreviously we have shown that it is possible to target retroviral vectors to cells using avi...
AbstractRedirecting retroviral vector transduction simply by insertion of a ligand into the envelope...
A potentially powerful approach for in vivo gene delivery is to target retrovirus to specific cells ...
A potential approach to in vivo gene therapy is to target retrovirus to specific receptors through a...
In the accompanying study, we show how retroviral tropism can be redirected by insertion of short pe...
AbstractTargeted gene transfer into human cells has previously been achieved with spleen necrosis vi...
Targeted gene transfer into human cells has previously been achieved with spleen necrosis virus (SNV...
It is known that targeted infection requires the modification of the viral envelope, in order to ren...
Retroviral vectors have been widely used in human gene therapy protocols. Entry into target cells is...
International audienceThe Epstein-Barr virus basic leucine zipper transcriptional activator ZEBRA wa...
Retrovirus entry into cells is mediated by specific interactions between the retrovirally encoded En...
Successful gene therapy for breast and ovarian cancer will likely require that anti-cancer genes be ...
Murine leukemia virus ecotropic and amphotropic envelope expression vectors were genetically enginee...
AbstractWe have constructed chimeric retroviral envelopes displaying N-terminal polypeptides that ar...
We constructed a hybrid Moloney murine leukaemia virus (MoMLV) bearing both a chimeric CD4 and the w...
AbstractPreviously we have shown that it is possible to target retroviral vectors to cells using avi...
AbstractRedirecting retroviral vector transduction simply by insertion of a ligand into the envelope...
A potentially powerful approach for in vivo gene delivery is to target retrovirus to specific cells ...
A potential approach to in vivo gene therapy is to target retrovirus to specific receptors through a...
In the accompanying study, we show how retroviral tropism can be redirected by insertion of short pe...
AbstractTargeted gene transfer into human cells has previously been achieved with spleen necrosis vi...
Targeted gene transfer into human cells has previously been achieved with spleen necrosis virus (SNV...
It is known that targeted infection requires the modification of the viral envelope, in order to ren...
Retroviral vectors have been widely used in human gene therapy protocols. Entry into target cells is...
International audienceThe Epstein-Barr virus basic leucine zipper transcriptional activator ZEBRA wa...
Retrovirus entry into cells is mediated by specific interactions between the retrovirally encoded En...
Successful gene therapy for breast and ovarian cancer will likely require that anti-cancer genes be ...
Murine leukemia virus ecotropic and amphotropic envelope expression vectors were genetically enginee...
AbstractWe have constructed chimeric retroviral envelopes displaying N-terminal polypeptides that ar...
We constructed a hybrid Moloney murine leukaemia virus (MoMLV) bearing both a chimeric CD4 and the w...
AbstractPreviously we have shown that it is possible to target retroviral vectors to cells using avi...